Home
Transactions

Work Area: Transactions

Your guide to synthetic drug royalty dealmaking

Selling revenue streams is an increasingly important way of monetising pharma innovations

Five key patent transactions takeaways

An over-arching theme during an IAM event was the key importance of relationships, trust and empathy between parties when deals are getting done

WiLAN revenues plummet in Q3 on prior year but Micron deal excluded

Strategic review of the licensing business nears a year in motion with no news on potential divestment announced

Latest content

For Taiwan firms, the time is now for patent monetisation

Recent moves by MediaTek, Asus and Acer all show that IP owners are seeking to boost returns

20 January 2022

IAM Strategy 300 experts share deals market outlooks for 2022

A 'bear trap' in China, ongoing US validity woes and big M&A opportunities around established brands and IP are among trends highlighted by practitioners

17 January 2022

Rise of AI continues to re-write life sciences IP strategies in 2022

A spate of pharma-high tech innovation partnerships have dominated opening days of the year

11 January 2022

Panasonic closes patent transactions with major LED and OLED players

Lighting firm Signify and panel-maker Samsung Display each acquired portfolios from one of Japan’s leading IP dealmakers last month

10 January 2022

Patent marketplace has been the unsung hero of the remote work era

Saturday Opinion: Technology solutions that have helped the world through the pandemic would look very different absent a sophisticated IP licensing ecosystem, argues Dolby GC Andy Sherman

08 January 2022

How looming patent cliffs are impacting pharma IP strategies

Major IP expiries on the horizon are not only shaping pharma dealmaking patterns, but are likely to lead to further patent thicket disputes.

05 January 2022

What’s ahead for the global IP market in 2022

Predictions from the IAM editorial team on what the next twelve months have in store

03 January 2022

BlackBerry patent sale almost there but still not over the line

“We are literally down to the last few important items now,” says company CEO John Chen on Q3 earnings call

22 December 2021

It’s a big 48 hours for BlackBerry and the patent market in general

The company is due to release its Q3 financials tomorrow, but it is not known whether the touted sale of a portfolio of well over 30,000 individual assets will also be announced

20 December 2021

Chinese appliance maker scores $26 million win with patent bought from Toshiba

Sizeable damage award against top white goods maker Gree vindicates smaller rival’s strategy for playing IP catch-up through transactions

14 December 2021

Unlock unlimited access to all IAM content